PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
4don MSN
Nebraska Hematology Oncology becomes state’s only trial site for new prostate cancer treatment
The treatment, called Pasritamig, teaches the immune system's T cells to target and attack cancer cells in the prostate.
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.
A pioneering new therapy will 'transform' treatment, according to health chiefs.
Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...
Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results